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INTRODUCTION
ALS is a late-onset neurodegenerative dis-
ease of unknown etiology. Since it was first
described (Charcot, 1874), several mech-
anisms, such as oxidative stress, gluta-
mate excitotoxicity, glial cell pathology, or
aberrant RNA metabolism (for review, see
Vucic and Kiernan, 2009). Recently the
evidence accumulates that mitochondrial
damage and defective axonal transport
may play a pivotal role (Shi et al., 2010;
Cozzolino and Carri, 2012). Nowadays,
a multifactorial origin is widely accepted
for the neurodegeneration in ALS, but
the triggering mechanism(s) underlying
its initiation remain to be defined.
One of the issues, which are still unre-
solved, is the triggering site. ALS is clas-
sically thought to be a disease that causes
the progressive loss of upper and lower
motoneurones (MNs) followed by axonal
degeneration and muscle atrophy, result-
ing in the virtually complete disappear-
ance of spinal and cortical MNs (Charcot,
1874; Strong and Rosenfeld, 2003). This
point of view is still prevalent among
clinical neurologists, and ongoing debates
focus mostly on the question of which MN
subsystem (upper or lower) is affected first
(Chou and Norris, 1993; Eisen et al., 1996;
Eisen, 2009; Van Der Graaff et al., 2009).
For obvious reasons, it is not possible to
directly characterize the properties ofMNs
in ALS patients. Therefore, a significant
proportion of the research on ALS takes
place in animal models of the disease that
carry mutations in the Cu/Zn superoxide
dismutase gene (the SOD1 mice and rats).
Although these mutations are responsible
only for about 2.5% of all the ALS cases,
the pathology in SOD1 animals largely
resembles clinical features of human spo-
radic ALS.
In recent years, research in SOD1 ani-
mal ALS models has found MN pathology
to begin at the distal axon terminals and to
proceed in a “dying back” pattern (Fischer
et al., 2004; Xie et al., 2005; Parkhouse
et al., 2008; Sotelo-Silveira et al., 2009;
Carrasco et al., 2010). Below, we will
present a piece of experimental evidence
that, in our opinion, may be interpreted in
favor of this last view.
THE SINGLE MOTOR UNIT CASE
The detailed information on the meth-
ods applied and the patients investigated
is given in the study published earlier
(Piotrkiewicz et al., 2008). Briefly, in the
study participated 20 patients, aged 31–75
(mean 55.0 years) and diagnosed as having
definite ALS according to El Escorial crite-
ria (Brooks, 1994). Motor unit potentials
(MUPs) were picked up from the brachial
biceps by intramuscular disposable wire
electrodes, amplified and transferred for
off-line analysis to a PC computer by an
A/D converter with sampling rates 10–
20 kHz.
Among 124 single motor units (MUs)
analyzed in this study we found one (E-
MU), which strikingly differed from all
others. It was recorded from the brachial
biceps of 49 years old patient with 50%
force deficit (as compared with average
maximum force of control subjects). The
firing pattern of the E-MU was very irreg-
ular, which could not be ascribed to the
fluctuating synaptic inflow, since the other
MU (N-MU) recorded simultaneously dis-
charged very regularly (Figure 1A).
E-MU exhibited also an exceptional
variability of potential shape due to the
high jitter and changes in the number
of individual components (Figure 1B). It
was often difficult to decide, whether
the given component was an integral
part of MU potential that was some-
times blocked, a satellite, a doublet of the
motoneuronal origin, or ectopic discharge.
Because of these ambiguities E-MU was
excluded from the analysis of doublet
firing. Figure 1C presents the interspike
interval histogram of E-MU, compared
with that of N-MU. The initial peak of
this histogram (0–20ms), which includes
the short intervals between potential pairs
recognized as doublets, is presented with
expanded time scale and shorter bin width
in the insert to Figure 1C. The follow-
ing maximum (at 85ms) corresponds
to the regular discharges and the next
one (at 120ms) is due to the prolonged
post-doublet intervals, typical feature of
double discharges. The histogram reveals
also several intervals, so-called “outsiders,”
which duration is longer than officially
accepted upper limit of doublet intervals
(20ms, according to AAEM, 2001), but
shorter than the lower limit of the regular
interval histogram. In our previous study
(Piotrkiewicz et al., 2008) such pairs of
potentials were classified also as doublets,
since their intervals were visibly shorter
and always followed by post-doublet inter-
val significantly longer as compared with
the regular discharge. The E-MU dis-
charge was characterized by exceptionally
high percentage of “outsiders,” as com-
pared with other doubling MUs from ALS
patients.
POSSIBLE EXPLANATION
De Carvalho (2000) described two dis-
tinct types of fasciculation potentials
recorded from ALS patients. Fasciculation
potentials of the first type, which were usu-
ally recorded from strong muscles, were
stable, simple and the same potentials
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FIGURE 1 | Characteristics of E-MU: (A) discharge patterns: upper trace,
N-MU; lower trace, E-MU. Each discharge represented by a vertical line;
(B) a variety of E-MU potential shapes; (C) histograms of interspike intervals:
N-MU, thick red line, shaded area, E-MU, thin blue line, open area; insert:
histogram of doublet and “outsider” intervals of E-MU in expanded scale. Bin
width: 5ms for pooled histogram, 0.4ms for inset.
could be recruited both voluntarily and
by transcranial magnetic stimulation.
Fasciculation potentials of the second type
were complex, unstable, tended to have
lower discharge rates and were generated
only spontaneously. It was suggested that
the fasciculations of the first type arise at
the spinal (or upper) MN level and those
of the second type, in distal axonal sprouts.
This suggestion was further confirmed by
a recent study of Kleine et al. (2008).
In SOD1 mice (animal model of ALS).
Schaefer et al. (2005) found two popula-
tions of MUs: one (1) with well-preserved
axonal branches, sometimes enlarged as
the result of reinnervation, and the other
(2) with degenerating axon terminals,
sometimes with no neuromuscular con-
tacts at all. The latter finding is in line with
growing number of studies in SOD1 mice
suggesting that the disease may start in
neuromuscular junction and proceed with
the “dying-back” pattern through an axon
to the MN (e.g., Fischer et al., 2004).
If also in the human sporadic ALS
the disease began in motor endplates,
then one might expect the presence of
two populations of MUs: one which is
still intact and the other being under
process of losing their neuromuscular con-
tacts and thus on the way to degener-
ation. The first one would correspond
to the population (1) in Schaefer’s study
and would produce fasciculations of de
Carvalho’s first type as well as doublets,
both generated by hyperexcitable MNs.
The second one would correspond to the
Schaefer’s population (2); the affected,
hyperexcitable axonal collaterals (Bostock
et al., 1995) could generate ectopic activ-
ity (fasciculations of de Carvalho’s sec-
ond type). Our MU with unstable poten-
tial shape, irregular low-rate discharge, big
percentage of “outsiders,” but still under
voluntary control, might represent the
intermediate type: a MU, which is loosing
contacts with its muscle fibers. It is con-
ceivable that the time from the first notice-
able symptoms to the complete loss of MN
control upon its muscle unit may be short
and thus the majority of MUs, which can
be voluntarily driven, would belong to the
yet unaffected population. This may be the
reason why among 124 analyzed ALS MUs
we found only one with the characteristics
described above.
CONCLUDING REMARKS
Could it be possible that human ALS also
begins in motor endplates and proceeds
via axons in a “dying-back” pattern?
In fact, abnormalities in motor
axon properties are often reported in
ALS patients (Bostock et al., 1995;
Mogyoros et al., 1998; Stephanova et al.,
2001; Priori et al., 2002; Koszewicz et al.,
2005; Kanai et al., 2006; Vucic and
Kiernan, 2006). The pathology of motor
axons has been shown to be more pro-
nounced distally (Nakata et al., 2006; Noto
et al., 2011). Certain lines of evidence
derived from clinical neurophysiology of
ALS (Eisen and Swash, 2001) could be
also interpreted as favoring the “dying
back” hypothesis of MN degeneration.
For example, the marked fatigue observed
early in the disease could indicate an end-
plate dysfunction. The routine test to
diagnose the impairment of neuromus-
cular transmission in Myasthenia gravis,
typical motor endplate disease, is the
investigation of change in MU potential
amplitude due to repetitive nerve stimula-
tion. The amplitude decrements in such a
test indicate the impairment of neuromus-
cular transmission. Decremental responses
to stimulation were observed also in ALS
(Bernstein and Antel, 1981; Killian et al.,
1994; Wang et al., 2001). Iwanami and
colleagues (2011) found even the inci-
dence of positive decrements higher in
the ALS than in the Myasthenia gravis
patients.
The ongoing debates between clini-
cal neurologists focus essentially on the
question of which MN subsystem is
affected first. The term “dying back”
was used in this debate to character-
ize the hypothesis that the ALS is pri-
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marily a lower MN disease spreading to
upper MNs (Van Der Graaff et al., 2009).
However, if ALS pathology indeed began
in axons, then the lower and upper MNs
could degenerate independently of each
other. This possibility was recently sug-
gested by several authors (Terao et al.,
1999; Attarian et al., 2008; Agosta et al.,
2009).
Recently, the question of possible het-
erogeneity of ALS is often raised (Adamek
et al., 2002; Beghi et al., 2007; Bastos et al.,
2011; Chiò et al., 2011; Van Den Berg,
2011). It is thus possible that different ALS
phenotypes may be initiated at different
sites. In any case, the proper defining of
disease initiation site would be an impor-
tant step toward eventual discovery of the
factor triggering the disease and the target
of its possible treatment.
In this opinion we concentrated on the
problem of ALS initiation site, favoring
one of several possibilities. We are aware
that there could be an alternative expla-
nation of firing patterns observed in our
E-MU. If, however, this paper evokes a dis-
cussion on the possible initiation site of
ALS, this may be a little step toward final
unraveling of ALS etiology.
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